Company Directory - Cardinal Health, Inc.
CCI Score
CCI Score: Cardinal Health, Inc.
-0.73
Latest Event
Cardinal Health Political Contributions and Lobbying Profile
OpenSecrets data reveals that in the 2024 cycle, Cardinal Health contributed $561,811 and spent $1,920,000 on lobbying. The profile also notes that a significant portion of its lobbyists have prior government experience, indicating a revolving door that can exacerbate undue corporate influence over policymaking.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
BYSTANDER
Cardinal Health, Inc. is currently rated as a Bystander.
Latest Events
FEB062025OpenSecrets data reveals that in the 2024 cycle, Cardinal Health contributed $561,811 and spent $1,920,000 on lobbying. The profile also notes that a significant portion of its lobbyists have prior government experience, indicating a revolving door that can exacerbate undue corporate influence over policymaking.
-40
Political Contributions and Lobbying Efforts
April 2
The reported figures for political contributions and particularly lobbying expenditures point to vigorous corporate engagement in political influence. Such high levels of spending can help secure favorable regulatory outcomes and sustain power structures that undermine democratic accountability, aligning with concerns about authoritarian tendencies.
-40
Executive Political Engagement
April 2
The data shows that a substantial portion of Cardinal Health's lobbyists had previous government roles. This revolving door phenomenon can lead to regulatory capture, where former public officials use their inside knowledge and connections to influence policy in favor of corporate interests, thereby contributing to authoritarian governance structures.
- FEB062025
Cardinal Health's PAC contributed $310,500 to federal candidates in the 2023-2024 election cycle, as reported by OpenSecrets, based on FEC data released on February 06, 2025.
-40
Political Contributions and Lobbying Efforts
April 2
The $310,500 contribution by Cardinal Health’s PAC to federal candidates reflects corporate political financing that enables influence over public policy. Despite the relative size of the donation compared to the company’s vast revenue, such contributions can contribute to imbalances in political power and potential favoritism towards corporate interests.
Cardinal Health PAC Contributions to Federal Candidates • OpenSecrets
- JAN012025
Cardinal Health has published its Policies and Principles page, which includes a Global Human Rights and Labor Standards policy outlining guidelines for interactions with employees, suppliers, and vendors to ensure compliance with US and international laws.
+40
Labor Relations and Human Rights Practices
April 2
The publication of a Global Human Rights and Labor Standards policy demonstrates Cardinal Health's commitment to upholding labor rights and human dignity. This policy sets clear guidelines for fair treatment and compliance with labor standards, reflecting a positive anti-fascist stance by supporting workers' rights and ethical business practices.
- OCT012024
Cardinal Health released its 2024 Political Activities and Contributions Report detailing its approach to political engagement. The report emphasizes that all political contributions to federal and state candidates were made through the employee-funded PAC, except for a $20,000 corporate contribution made in October 2024 to oppose Oregon’s Measure 118, a ballot initiative aimed at modifying the state's corporate minimum tax statute. In addition, the report outlines extensive federal and state lobbying activities along with established governance and board oversight over these political expenditures.
-20
Political Contributions and Lobbying Efforts
March 29
The report reveals that while Cardinal Health primarily channels political contributions through its employee-funded PAC—ensuring a level of transparency and distancing corporate funds from direct political spending—the instance of a $20,000 corporate contribution to oppose Oregon’s Measure 118 raises concerns. This use of corporate funds to influence tax policy appears to protect corporate interests over broader democratic reforms, thereby earning a negative score in the realm of Political Contributions and Lobbying Efforts.
PDF 2024 Political Activities and Contributions Report - Cardinal Health
+10
Business Practices and Ethical Responsibility
March 29
The report is marked by clear corporate governance features including strict adherence to political contributions policies, regular oversight by the Governance and Sustainability Committee, and transparency in disclosing lobbying expenditures. These practices reflect responsible business practices and ethical responsibility, mitigating some concerns despite the isolated use of corporate funds.
PDF 2024 Political Activities and Contributions Report - Cardinal Health
- APR022024
Cardinal Health’s U.S. medical products distribution business has been recognized with the HIRC Resiliency Partner Badge at Diamond-level for its outstanding supply chain resiliency, demonstrating robust supply chain practices that underpin reliable healthcare delivery.
+85
Supply Chain Ethics
March 29
Achieving the Diamond-level HIRC Resiliency Badge indicates that Cardinal Health has established highly resilient and ethically managed supply chain practices. This award reflects a strong commitment to upholding standards that ensure patient access to critical medical products without contributing to any authoritarian practices.
Cardinal Health awarded highest accolades for supply chain resiliency
- MAR012024
In 2023, Cardinal Health released a comprehensive political activities report detailing its political contributions channeled exclusively through its employee-funded Political Action Committee and outlining significant federal and state lobbying expenditures. The report emphasizes adherence to a formal corporate political contributions policy and oversight by its Governance and Sustainability Committee.
+15
Political Contributions and Lobbying Efforts
March 29
Cardinal Health ensures that all political contributions in 2023 were made through its employee-funded PAC rather than with corporate funds, which demonstrates transparency and limits undue corporate influence. However, the substantial lobbying expenditures at both the federal and state levels highlight a significant engagement in shaping policy, warranting a moderate positive score under Public and Political Behavior from an anti-authoritarian perspective.
PDF 2023 Political Activities and Contributions Report - Cardinal Health
+10
Executive Political Engagement
March 29
The report outlines active oversight by Cardinal Health's Governance and Sustainability Committee and involvement by senior executives, which indicates responsible executive political engagement and a level of accountability in its political actions. While this oversight is a positive mechanism, the overall extensive lobbying efforts moderate the score slightly.
PDF 2023 Political Activities and Contributions Report - Cardinal Health
- JAN012024
The OpenSecrets profile outlines Cardinal Health's extensive lobbying activities dating back to 1998, including efforts on bills in 2024. This showcases the company's long-term involvement in influencing policy decisions and its potential impact on democratic processes.
-50
Political Contributions and Lobbying Efforts
March 29
The profile from OpenSecrets documents Cardinal Health's longstanding engagement in lobbying, a tactic that consolidates corporate influence over government policy. This form of political involvement can undermine democratic accountability and worker rights, aligning with practices that support authoritarian power structures.
- DEC312023
Cardinal Health’s 2023 Political Activities and Contributions Report details that all political contributions were executed solely through its employee-funded Political Action Committee (PAC), with strict oversight by its Governance and Sustainability Committee, and outlines significant lobbying activities undertaken at both the federal and state levels. The report underscores the company’s commitment to transparency by separating corporate funds from political contributions and maintaining rigorous procedural checks, despite sustaining substantial lobbying expenditures.
+35
Political Contributions and Lobbying Efforts
April 2
The report emphasizes that Cardinal Health channels its political contributions exclusively through its PAC, which is fully funded by employee contributions rather than corporate funds. This practice demonstrates a commitment to maintaining a clear separation between corporate resources and political spending, thereby enhancing transparency and reducing the risk of corporate overreach into political processes.
PDF 2023 Political Activities and Contributions Report - Cardinal Health
+15
Executive Political Engagement
April 2
The report details structured executive involvement through the Governance and Sustainability Committee's oversight of political contributions and lobbying activity. While this demonstrates an effort towards responsible political engagement and compliance with regulatory frameworks, the significant lobbying expenditures still warrant caution regarding the extent of corporate influence on public policy.
PDF 2023 Political Activities and Contributions Report - Cardinal Health
- NOV062023
Cardinal Health released its Fiscal 2023 Modern Slavery Statement in compliance with the U.K. Modern Slavery Act 2015, outlining comprehensive measures to prevent modern slavery and human trafficking in its business operations and global supply chains. The document details robust vendor codes, labor standards policies, supplier audits, and training protocols aimed at safeguarding workers' rights and ensuring ethical sourcing practices.
+50
Labor Relations and Human Rights Practices
April 2
The statement emphasizes adherence to internationally recognized human rights and labor standards, including zero tolerance for forced labor, child labor, and harassment. These measures contribute to a more secure and equitable working environment, bolstering worker rights and demonstrating progressive practices.
+60
Supply Chain Ethics
April 2
Cardinal Health’s statement provides detailed insights into its ethical sourcing, vendor code of conduct, and supplier audit processes. These initiatives aim to mitigate modern slavery risks in extensive global supply chains, reflecting a commendable commitment to supply chain transparency and ethical responsibility.
- OCT012023
Cardinal Health agreed to pay $1.45 million and implement systemic reforms including discrimination training, a toll-free complaint hotline, and extended oversight as part of a settlement resolving a lawsuit over racial harassment and retaliation allegations by the EEOC.
-80
Labor Relations and Human Rights Practices
March 29
The lawsuit revealed systemic failures in protecting African American employees from racial harassment and retaliation, evidencing a serious breach of labor rights. Although the settlement mandates improved practices such as discrimination training and a complaint hotline, the underlying misconduct significantly undermines worker rights and raises concerns of corporate complicity in perpetuating hostile work environments.
Cardinal Health and AppleOne Settle EEOC Race Harassment/Retaliation Lawsuit
- OCT012023
Cardinal Health published its policies and principles page outlining modern slavery statements in compliance with the U.K. Modern Slavery Act 2015 and the Canadian legislation on forced labour. The page details guidelines on interactions with suppliers and vendors to prevent human trafficking and forced labour in its supply chain.
+60
Supply Chain Ethics
October 1
By publicly publishing modern slavery statements and outlining measures to prevent forced labour and human trafficking in its business and supply chain, Cardinal Health demonstrates a commitment to ethical business practices and worker rights. This action aligns with anti-authoritarian values by upholding international labour standards and ensuring supply chain transparency.
- OCT012023
Cardinal Health has published its policies outlining guidelines for respecting human rights, labor standards, and ethical interactions with suppliers and vendors in compliance with U.S. laws and international norms.
+40
Labor Relations and Human Rights Practices
March 29
By establishing a Global Human Rights and Labor Standards policy, Cardinal Health demonstrates a commitment to upholding ethical labor practices and protecting workers' rights, which aligns with progressive, anti-authoritarian values.
+30
Supply Chain Ethics
March 29
The policy also explicitly addresses expectations for interacting with suppliers and vendors, indicating a proactive approach to ethical supply chain management and support for human rights across its business practices.
- OCT012023
The FEC committee overview for Cardinal Health Inc. PAC provides details on its financial contributions—such as $460,000 donated to other committees—underscoring the company's involvement in political financing. This information raises concerns about the potential for corporate influence over political processes, which may ultimately serve to bolster authoritarian dynamics.
-30
Political Contributions and Lobbying Efforts
March 29
The documented political contributions via the Cardinal Health Inc. PAC suggest that the company is engaging in practices that could enable undue corporate influence in politics. From an anti‑fascist perspective, such financial interventions in the political arena are problematic as they risk amplifying power imbalances and undermining democratic processes.
- APR262023
Cardinal Health executives, including the CEO of its Pharmaceutical Segment and the Chief Legal and Compliance Officer, visited Capitol Hill to meet with multiple members of Congress and discuss legislative priorities affecting the company and its customers. The visit also included attending a political action committee reception and engaging with key industry partners.
-20
Executive Political Engagement
March 29
Cardinal Health's high-level executive engagement on Capitol Hill underscores targeted corporate lobbying efforts. While political engagement is routine, using executive influence to shape legislative outcomes raises concerns about corporate influence over democratic processes. This behavior can contribute to an erosion of public trust in impartial governance, fitting poorly with anti-authoritarian democratic principles.
- APR192023
Cardinal Health's executives, including the CEO of its Pharmaceutical Segment and the Chief Legal and Compliance Officer, met with several members of Congress and attended a PAC reception on April 19, 2023. The meetings focused on legislative and policy issues affecting the company and its customers, reflecting a strategy of corporate political engagement.
-30
Executive Political Engagement
April 2
Cardinal Health executives actively engaging with lawmakers on Capitol Hill—including attending a PAC reception—demonstrates a clear instance of executive political engagement. Such corporate lobbying efforts have the potential to reinforce the undue influence of business interests on policy-making, thereby detracting from democratic accountability and compromising public interests and worker rights.
- MAR012023
Cardinal Health is identified as a founding member and part of the inaugural steering committee of the Responsible Glove Alliance, an initiative aimed at preventing and remediating forced labor in the medical supplies industry in Malaysia.
+70
Supply Chain Ethics
March 29
By joining the Responsible Glove Alliance and taking an active role in its steering committee, Cardinal Health demonstrates a commitment to ethical supply chain practices by working to prevent forced labor in the medical supplies industry. This proactive engagement enhances labor rights and ethical sourcing measures.
- JAN262023
On January 26, 2023, Cardinal Health announced a strategic collaboration with Palantir to integrate AI-driven decision support into its pharmaceutical supply chain. The solution aims to combine clinical and purchasing data to improve inventory management, reduce drug shortages, and enhance patient outcomes.
+40
Business Practices and Ethical Responsibility
April 2
The initiative demonstrates a commitment to responsible business practices by striving for greater transparency and efficiency in the pharmaceutical supply chain. By leveraging integrated data to address drug shortages and rising costs, Cardinal Health is working to ensure better access to essential medications, which aligns with ethical supply chain management and supports vulnerable populations.
Cardinal Health Teams Up with Palantir to Deliver a Clinically Integrated Supply Chain Solution
+30
Technology and Services Impact
April 2
The collaboration leverages advanced technologies such as artificial intelligence and machine learning to analyze diverse data sets for real-time supply chain optimization. This innovative application of technology boosts operational resilience and patient care within the healthcare sector, reflecting a progressive use of tech in service of public health.
Cardinal Health Teams Up with Palantir to Deliver a Clinically Integrated Supply Chain Solution
- MAR012022
Cardinal Health, along with six founding partners, launched the Responsible Glove Alliance in March 2022 to mitigate forced labor risks and improve human rights and ethical practices within the global rubber glove supply chain.
+85
Labor Relations and Human Rights Practices
April 2
Cardinal Health's initiative to join and help launch the Responsible Glove Alliance underlines a robust commitment to protecting worker rights and improving labor practices in the glove manufacturing industry, particularly benefiting vulnerable migrant workers at risk of forced labor.
Protecting human rights through the Responsible Glove Alliance
+85
Supply Chain Ethics
April 2
By participating in the Responsible Glove Alliance, Cardinal Health demonstrates proactive measures to enhance supply chain ethics, ensuring rigorous standards and transparency in sourcing, which is crucial to preventing exploitation and forced labor in production.
Protecting human rights through the Responsible Glove Alliance
- JAN312022
Cardinal Health, Inc. agreed to pay $13,125,000 to resolve allegations that it violated the Anti-Kickback Statute and False Claims Act by offering upfront discounts, effectively paying cash bonuses to recruit new customers. This kickback scheme risked perverting clinical decision-making and undermining public trust in the federal healthcare system.
-80
Business Practices and Ethical Responsibility
March 29
Cardinal Health's practice of offering illegal cash bonuses as upfront discounts to secure new physician customers constitutes unethical business practices that compromise clinical decision-making and defraud public health programs. The violation of the Anti-Kickback Statute and False Claims Act undermines the integrity of the healthcare system, with significant negative societal implications.
- JAN212022
Cardinal Health, Inc. entered into a settlement agreement with the US government, agreeing to pay over $13 million. The agreement follows allegations that the company made upfront payments to physician practices to induce the purchase of its pharmaceutical products, resulting in false claims submitted to Medicare and Medicaid in violation of the Anti-Kickback Statute.
-60
Business Practices and Ethical Responsibility
March 29
The settlement reveals unethical business practices wherein Cardinal Health made upfront payments to physicians to secure purchases, ultimately resulting in false claims to federal healthcare programs. This behavior undermines corporate accountability and harms vulnerable populations relying on Medicare and Medicaid, representing a negative action under Business Practices and Ethical Responsibility.
- JUL122021
Cardinal Health, along with AppleOne, agreed to a $1.45 million settlement to resolve an EEOC lawsuit alleging racial harassment and retaliation. As part of the settlement, the company will implement injunctive relief measures including enforced policy audits, discrimination training, and the establishment of internal complaint procedures to address and prevent future misconduct.
-40
Labor Relations and Human Rights Practices
April 2
The lawsuit revealed significant issues related to racial harassment and retaliation of African American employees, representing a severe lapse in ensuring a safe and inclusive work environment. Although the settlement mandates corrective measures such as enhanced training, internal audits, and monitoring, the underlying behavior that led to the legal action reflects negatively on the company's labor relations and human rights practices.
Cardinal Health and AppleOne Settle EEOC Race Harassment/Retaliation Lawsuit
- DEC232016
Cardinal Health has agreed to pay $34 million in civil penalties to resolve allegations of failing to report suspicious orders of Class II controlled substances. The settlement highlights serious lapses in regulatory compliance and corporate accountability.
-40
Business Practices and Ethical Responsibility
March 29
Cardinal Health’s failure to report suspicious orders and the resulting $34 million settlement demonstrate a significant breach in ethical business practices and regulatory compliance, thereby undermining public trust and accountability.
- APR202015
Cardinal Health, Inc. agreed to pay $26.8 million to settle charges brought by the FTC for monopolizing 25 local radiopharmaceutical markets by engaging in coercive and exclusionary practices that blocked competition and inflated prices. The settlement includes measures to bar exclusive deals and enforce an antitrust compliance program.
-60
Business Practices and Ethical Responsibility
March 29
Cardinal Health's actions to coerce manufacturers and block competitors represent unethical business practices that harm market fairness and consumer interests. Such anticompetitive behavior contributes to a concentration of corporate power, undermining democratic economic practices.
-50
Economic and Structural Influence
March 29
The company's monopolistic conduct resulted in market domination and economic harm by preventing new competitors from entering the market, thus entrenching unequal power dynamics and adversely impacting consumer welfare.
- OCT022008
In October 2008, Cardinal Health agreed to pay $34 million to settle claims that it failed to report suspicious orders of controlled substances to the DEA, a negligence that allowed diversion of hydrocodone and contributed to broader issues of pharmaceutical abuse.
-60
Business Practices and Ethical Responsibility
March 29
Cardinal Health’s failure to report suspicious orders of controlled substances represents a significant breach of ethical business practices. This negligence allowed the diversion of hydrocodone, contributing indirectly to widespread pharmaceutical abuse. Such corporate misconduct undermines public trust in regulatory compliance and reflects poorly on the company’s commitment to responsible business practices.
Alternatives
Hong Kong, Hong Kong
0.00
Woonsocket, USA
-46.49
Corporation
-0.57
Corporation
-12.36
Corporation
-24.77
Dallas, United States
4.64
Washington, United States
4.01
Irving, United States
-17.26
Baltimore, United States
-20.95
United States
-27.89
Corporate Financials
- Revenue
- 2025
- $188.00B
- Total Assets
- 2025
- $51.20B
- Operating Income
- 2025
- $4.10B
- Total Equity
- 2025
- $8.00B
Employees: 43,000
Industries
- 423450
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
- 424210
- Drugs and Druggists' Sundries Merchant Wholesalers
- 541713
- Research and Development in Nanotechnology
- 621610
- Home Health Care Services
- 541710
- Research and Development in the Physical, Engineering, and Life Sciences